Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,101 public trials 617 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Active, Not Recruiting

Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in China

NCT05144243

Conditions
Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Peking Union Medical College Hospital (East) - Dongdan Campus /ID# 233179 Beijing, Beijing Municipality, China
  • Peking University International Hospital /ID# 232254 Beijing, Beijing Municipality, China
  • Sun Yat-Sen University Cancer Center /ID# 231793 Guangzhou, Guangdong, China
  • Zhujiang Hospital of Southern Medical University /ID# 231792 Guangzhou, Guangdong, China
View all 18 locations
View Trial Details
Active, Not Recruiting

Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT03190278

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +5 more
Locations
  • University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome

NCT02521493

Conditions
Abnormalities, Multiple, Acute Myeloid Leukemia, Bone Marrow Diseases, +21 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 191 locations
View Trial Details
Active, Not Recruiting

Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics

NCT03897127

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Medizinische Universität Graz Graz, Austria
  • Tirol Kliniken GmbH Innsbruck Innsbruck, Austria
  • Ordensklinikum Linz GmbH, Elisabethinen Linz, Austria
  • Feldkirch, Landeskrankenhaus Rankweil, Austria
View all 62 locations
View Trial Details
Active, Not Recruiting

Study of Anti-CD33 Chimeric Antigen Receptor-Expressing T Cells (CD33CART) in Children and Young Adults With Relapsed/Refractory Acute Myeloid Leukemia

NCT03971799

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Children's Hospital of Colorado Aurora, Colorado, United States
  • National Cancer Institute - NIH Bethesda, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, Not Recruiting

FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies

NCT04891757

Conditions
Advanced Hematologic Malignancy, Bone Marrow Diseases, Chronic Disease, +19 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
View Trial Details

Related conditions